Medical Devices Startups
6,141 companies tagged Medical Devices, with their investors and founders.
Eyas Medical Imaging develops MRI technology designed specifically for imaging babies and infants. The company serves healthcare professionals and hospitals seeking precision imaging solutions for neonatal and pediatric patients.
2 investors
EyeYon Medical develops medical devices for corneal diseases, including EndoArt®, a synthetic implant for chronic corneal edema, and HyperCL™, a therapeutic contact lens for enhancing drug absorption in corneal conditions. The company serves ophthalmologists and patients requiring alternatives to traditional corneal transplantation.
2 investors
EyeControl builds a communication and engagement platform for critical care, helping hospitals support patient recovery and connection between patients, families, and medical teams, with capabilities extending to home care. It originated as an eye-based communication tool for patients unable to speak, such as those with ALS and other neurological conditions.
2 investors
Eyoto provides eye examination technology solutions for clinics, aiming to improve accessibility and efficiency of eye care delivery.
2 investors
A company developing eye-tracking technology for seizure detection and monitoring in patients with epilepsy. The platform combines machine learning and neuroscience expertise to support clinical epilepsy care and research.
2 investors
FASTinov develops phenotypic Antimicrobial Susceptibility Testing (AST) kits that deliver results within 2 hours directly from blood cultures, covering gram negative and gram positive panels. Its CE-marked in vitro diagnostic products serve clinical laboratories in the European Union.
2 investors
Fate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer. The company is conducting clinical trials on product candidates under strict regulatory and ethical standards.
2 investors
FeelTect develops connected-health devices for compression therapy in wound care and lymphoedema treatment. The company provides evidence-based solutions that allow healthcare providers to personalize therapy while improving patient outcomes and quality of life.
2 investors
Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases. The company specializes in its Feldan Shuttle peptide-based technology to deliver antisense oligonucleotides and other therapeutics to cellular targets, with current programs targeting basal cell carcinoma and respiratory diseases.
2 investors
FemDx Medsystems is a medical device company developing minimally invasive technologies for diagnosing and treating gynecological conditions, with a focus on reproductive health and gynecological cancers. Its flagship product, FalloView, is an FDA-cleared endoscope that gives physicians direct visualization of the fallopian tubes.
2 investors
FEops develops FEops HEARTguide, a cloud-based platform that uses AI and predictive simulation to analyze cardiac CT scans and plan structural heart procedures such as TAVI and left atrial appendage occlusion. It serves physicians and cardiovascular device companies, offering anatomical measurements, procedure planning, and finite element analysis services.
2 investors
Feyenally provides AI-powered eye testing through smartphone photos, generating refractive error measurements (spherical, cylindrical, and axis values) instantly from home without additional hardware. The company serves individuals seeking vision prescriptions and eye care accessibility.
2 investors
FH Ortho designs, manufactures, and distributes orthopedic medical devices such as joint implants for orthopedic surgeons and specialists. The French company, with over 60 years of activity, manufactures more than 95% of its products in France and focuses on implant research, development, and clinical follow-up.
2 investors
FICUS builds an AI-supported rehabilitation platform that reduces administrative work for German rehab clinics through connected documentation across all phases of patient care. It targets rehabilitation clinics and treatment teams facing staff shortages and administrative burden.
2 investors
Figure 1 is a peer-to-peer platform uniting verified healthcare professionals from over 190 countries to share medical knowledge, cases, and educational content. The platform hosts a library of 100,000+ de-identified patient cases and offers tools like medical quizzes and podcasts for clinical learning and collaboration.
2 investors
Firefly Bio develops antibody-drug conjugates (ADCs) that use novel classes of payloads, drawing on a research team experienced in ADC discovery and development. The company operates in the oncology and immunology biotech space.
2 investors
Flinn provides AI software for MedTech manufacturers to automate adverse event and safety database monitoring across 15+ regulatory databases such as FDA MAUDE, BfArM, and SwissMedic. The platform aggregates data, guides report evaluation, and generates audit-ready reports to support vigilance and regulatory compliance workflows.
2 investors
Flow Medical develops technology for catheter-directed thrombolysis treatment of pulmonary embolism, aiming to improve precision in lytic medication dosing to reduce readmission rates. The company targets interventional cardiologists and radiologists managing acute PE cases.
2 investors
FluoretiQ develops rapid point-of-care diagnostic tools that identify bacteria and determine effective antibiotics for veterinarians and clinicians, aiming to reduce reliance on empirical antibiotic treatment. Its NANOPLEX latex agglutination platform underpins its first product, VERI-5 VET, and its SCFI platform provides growth-free antibiotic susceptibility testing.
2 investors
Foqus Technologies develops software that uses quantum algorithms and AI to enhance MRI scans, aiming to increase magnetic resonance sensitivity, shorten scan times, and improve image quality without hardware upgrades. Its FDA 510(k) cleared and Health Canada licensed solution targets medical imaging for diagnosis and treatment monitoring.
2 investors
Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.
2 investors
Forcyte Biotechnologies develops drug screening tools that measure cell contractility to identify therapeutic candidates for diseases driven by abnormal cellular force generation, such as asthma, fibrosis, and hypertension.
2 investors
Forma Medical develops OptimalMTP, a minimally invasive surgical system for first metatarsophalangeal joint arthrodesis that combines plate-and-screw biomechanics with smaller incision techniques for foot surgeons.
2 investors
Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System. It plans to expand into bladder and kidney cancer applications, aiming to reduce the side effects associated with conventional prostate treatments.
2 investors